Medicaid expansion may improve childhood cancer survival

by Neil Schoenherr,Washington University in St. LouisCredit: Unsplash/CC0 Public DomainMedicaid expansion may improve outcomes for children with cancer, finds a new analysis from the Brown Schoo

Updated on: December 28,2023 8

Medicaid expansion may improve childhood cancer survival

by Neil Schoenherr,Washington University in St. LouisCredit: Unsplash/CC0 Public DomainMedicaid expansion may improve outcomes for children with cancer, finds a new analysis from the Brown Schoo

Updated on:December 28,2023 8

The Human Tumor Atlas Network: Mapping Cancer's Complexity and Evolution

The Human Tumor Atlas Network (HTAN) stands at the forefront of cancer research, representing a groundbreaking initiative funded by the National Cancer Institute (NCI) as part of the ambitious Cancer Moonshot℠ program. Launched in 2018, HTAN's primary mis

Updated on: November 07,2024 0

The Human Tumor Atlas Network: Mapping Cancer's Complexity and Evolution

The Human Tumor Atlas Network (HTAN) stands at the forefront of cancer research, representing a groundbreaking initiative funded by the National Cancer Institute (NCI) as part of the ambitious Cancer Moonshot℠ program. Launched in 2018, HTAN's primary mis

Updated on:November 07,2024 0

IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainPeople with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton

Updated on: October 24,2024 0

IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainPeople with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton

Updated on:October 24,2024 0

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on: January 21,2024 19

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on:January 21,2024 19

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q

Updated on: January 02,2024 9

AI-guided personalized drug combinations to treat relapsed lymphoma

byNational University of SingaporeAsst Prof Anand Jeyasekharan (left) and Assoc Prof Edward Chow (right) from the Cancer Science Institute of Singapore at NUS are pioneering the application of Q

Updated on:January 02,2024 9

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team

Updated on: June 11,2024 5

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team

Updated on:June 11,2024 5

New study finds millions in US missed cancer screening during second year of COVID-19 pandemic

byAmerican Cancer SocietyCredit: Unsplash/CC0 Public DomainAccording to a new, nationwide study led by researchers at the American Cancer Society (ACS), millions of people in the United States c

Updated on: January 15,2024 12

New study finds millions in US missed cancer screening during second year of COVID-19 pandemic

byAmerican Cancer SocietyCredit: Unsplash/CC0 Public DomainAccording to a new, nationwide study led by researchers at the American Cancer Society (ACS), millions of people in the United States c

Updated on:January 15,2024 12

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on: January 30,2024 14

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on:January 30,2024 14

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr

Updated on: January 30,2024 19

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr

Updated on:January 30,2024 19

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on: January 30,2024 12

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on:January 30,2024 12

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024 11

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024 11

Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainLike the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physi

Updated on: February 18,2024 20

Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainLike the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physi

Updated on:February 18,2024 20